RECRUITING
I'm interested ...!!
Pancreatic Cancer Detection Consortium
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
Conditions:
🦠 Pancreatic Cancer 🦠 Pancreatic Carcinoma 🦠 Pancreatic Adenocarcinoma 🦠 Pancreatic Ductal Adenocarcinoma 🦠 Pancreatic Neoplasms 🦠 Pancreatic Cancer Stage I 🦠 Pancreatic Cancer Stage 🦠 Pancreatic Cancer Resectable 🦠 Pancreatic Cancer Stage 0 🦠 Pancreatic Cancer Stage II 🦠 Pancreatic Cancer Stage III 🦠 Pancreatic Cancer, Adult 🦠 Pancreatic Cancer Non-resectable
More conditions available...
🗓️ Study Start (Actual) 15 March 2023
🗓️ Primary Completion (Estimated) 21 November 2025
✅ Study Completion (Estimated) 21 November 2025
👥 Enrollment (Estimated) 2000
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Phoenix, Arizona, United States
📍 Scottsdale, Arizona, United States
📍 Monrovia, California, United States
📍 Newport Beach, California, United States
📍 Peoria, Illinois, United States
📍 Jefferson, Louisiana, United States
📍 Morristown, New Jersey, United States
📍 Rock Hill, South Carolina, United States
📍 Milwaukee, Wisconsin, United States
📍 Nagoya, Japan
📍 Seoul, Korea, Republic of
More locations available...

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Histological diagnosis of pancreatic ductal adenocarcinoma, stages I-IV (TNM classification, 8th edition)
    • * Received standard diagnostic and staging procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment.
    • * Imaging- or endoscopy-based proof of lack of pancreatic ductal adenocarcinoma at the time of sampling (Non-disease controls)

    Exclusion Criteria:

    • * Lack of written informed consent.
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 19 April 2024
  • First Submitted that Met QC Criteria 24 April 2024
  • First Posted 29 April 2024

Study Record Updates

  • Last Update Submitted that Met QC Criteria 24 April 2024
  • Last Update Posted 29 April 2024
  • Last Verified April 2024
I'm interested ...!!